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Abstract
Background: The current COVID-19 pandemic highlights the challenges air ambulance services are facing when
transporting highly infectious patients for several hours in enclosed spaces. This overview provides an example of a
standard operating procedure (SOP) for infection prevention measures in HEMS missions during the COVID-19
pandemic. Furthermore, we describe different methods used by several organizations in Europe and the experience
of the Swiss air rescue organization Rega in transporting these patients.
Possible benefits of the use of small patient isolation units (PIU) are discussed, including the fact that
accompanying medical personnel do not need to wear personal protective equipment (PPE) during the transport
but can still maintain full access to the patient. Rega has developed and patented its own PIU. This device allows
spontaneously breathing or mechanically ventilated patients to be transported in pressurized jet cabins, small
helicopters and ambulance vehicles, without the need to change between transport units. This PIU is unique, as it
remains air-tight even when there is a sudden loss of cabin pressure.
Conclusion: A wide variety of means are being used for the aeromedical transport of infectious patients. These
involve isolating either the patient or the medical crew. One benefit of PIUs is that the means of transport can be
easily changed without contaminating the surroundings and while still allowing access to the patient.
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Background
During the current Coronavirus (COVID-19) pandemic,
ground and air rescue, rotary-wing (HEMS) and fixed-
wing (AEMS) emergency medical services are faced with
unprecedented challenges. While there are several rec-
ommendations for protective measures during in-
hospital emergency procedures and tracheal intubation,
there is insufficient guidance regarding the prehospital
setting [1]. Moreover, so far there are no published
guidelines on how to safely transfer COVID-19 patients.
Unfortunately, the disease transmission risk for aero-
medical crew members is higher than for in-hospital
healthcare providers, largely due to information, re-
sources and space being very limited in the prehospital
setting, and aerosol-generating procedures such as air-
way management and ventilation being one of the main
tasks. Different approaches are used to prevent
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transmission from patients with highly contagious infec-
tions during air transport. To address these issues we
have reviewed current concepts in aeromedical transport
in Europe, and we present the experience and recent
recommendations of the Swiss Air Rescue (Rega) for
COVID-19 and aeromedical transport.
Recommendations for HEMS missions during the COVID-
19 pandemic
Every air rescue provider should develop precise SOPs
for the use and handling of PPE during HEMS missions.
Especially during the current pandemic, with high num-
bers of infected patients (and individuals with unknown
COVID-19 status), strict adherence to these standards
on every mission is essential. Simulation training of
these special measures to prevent infection is highly rec-
ommended for every crew member, as this is known to
improve adherence to the SOPs [2, 3].
Table 1 provides an example of an SOP for infection
prevention measures in primary (and secondary) HEMS
missions during the COVID-19 pandemic, as used by
Rega.
During the COVID-19 pandemic, Rega has not used
closed suction catheters on primary missions or for
transfers between hospitals (secondary transport), and
their use is avoided even if they are pre-installed, due to
the risk of aerosol production from mobile suction units.
Furthermore, most patients with COVID-19 (without
bacterial superinfection) have only minor production of
bronchial secretions.
Secondary transport of COVID-19 patients
Air rescue providers use different concepts for the sec-
ondary transport of COVID-19 patients: open transport
systems that allow direct patient management through
the medical crew wearing PPE (e.g., FFP2/3 mask, gog-
gles or face shield, gloves and protective gown) through-
out the transport [4], or closed transport systems (so-
called air transport isolator systems) that were originally
developed for the fixed-wing transport of patients with
other highly contagious and dangerous diseases, such as
viral hemorrhagic fever.
There are two basic designs of these isolator systems:
closed patient isolation units (PIU), which separate the
patient from the medical crew (e.g., EpiShuttle®, Epi-
Guard HQ, Oslo Norway); Stretcher-Air Transport Iso-
lators (S-ATI), and the larger Trexler Air Transport
Isolator (T-ATI; Trexler Air Transport Isolator, UK,
United Kingdom and the Rega PIU (Fig. 1). Alterna-
tively, there are open systems which provide a portable
isolation facility large enough for both the patient and
attending medical staff wearing personal protective
equipment (e.g., multi patient transport unit, the Con-
tainerized Biological Containment System, CBCS, Phoe-
nix Arizona, USA). In the case of COVID-19, open PIUs
do not offer an additional benefit.
Table 2 provides an overview of current concepts used
by different air rescue providers in Europe for transport-
ing COVID-19 patients (as of April 5th, 2020; only pro-
viders with verified information are listed). Although the
authors have made considerable efforts to collect infor-
mation about transported COVID-19 patients and their
Table 1 Sample SOP “Infection prevention measures for HEMS missions during the COVID-19 pandemic”
CDR • Maintain a distance of at least two meters from the patient. If this is possible, wearing PPE is not mandatory. This applies to the site
where the HEMS crew is operating, as well as during the flight.
• Join the medical crew in the emergency department or intensive care unit only in exceptional cases. If so, wear the same personal
protective equipment as the medical crew.
MCM/
HCM
• Wear examination gloves, a filtering facepiece class 2 mask (FFP2/3), and goggles for eye protection on every mission. Carry a bottle of
hand disinfectant with you.
• If possible, maintain a distance of > 2 m from the patient during initial contact and while checking for COVID-19 risk factors
• Put a surgical mask over the patient’s mouth and nose or (depending on the clinical condition) a tight-fitting non-rebreather oxygen
mask with adequate oxygen flow and a surgical mask over the exhalation valves.
• Avoid aerosol-generating procedures such as non-invasive ventilation (NIV), high-flow oxygen therapy, tracheal suction, or nebulization
of medications.
• When planning for aerosol-generating procedures (mechanical ventilation, airway management, oral suction, cardiopulmonary resuscita-
tion, etc.), put on a protective gown (if time permits)
• Ventilator handover (e.g., emergency unit to Rega):
- Avoid unnecessary respirator circuit disconnections
- Set FiO2 to 1.0
- Check sedation/analgesia and relaxation (consider bolus administration if necessary)
- Prepare a generic self inflating bag with flexible tube extension and airway filter, plus reservoir bag including attached oxygen supply
- Switch the Rega ventilator device to standby mode
- Switch off the ventilator device of the emergency unit
- Clamp the tube between the patient and the filter
- Connect Rega ventilation tubes with airway filter
- Unclamp the tube
- Switch on the Rega ventilator system
- Verify correct positioning of the tube by using the CO2 curve on the Rega monitor and comparing ventilation settings, in particular the
ventilation pressure (avoid auscultation unless absolutely necessary)
CDR Commander, MCM doctor, HCM paramedic
Albrecht et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine           (2020) 28:40 Page 2 of 6
Fig. 1 Rega PIU AEMS
Table 2 Overview of transport concepts for secondary missions for COVID-19 patients
Germany German Armed
Forces
Fixed-wing (A310 MedEvac and A400M): ventilated patients and non-ventilated patients/stretchers in the A310
MedEvac; open cabin, medical crew wearing PPE
DRF Air Rescue Helicopter (H145): only ventilated patients, medical crew wearing PPE; soon closed PIU (EpiShuttle®)
ADAC Helicopter (H145): only ventilated patients, medical crew wearing PPE
Switzerland REGA Fixed-wing (CL650): Rega PIU
Helicopter (H145, AW109): medical crew wearing PPE, Rega PIU
Air Zermatt
Air Glacier
Helicopter (Bell 429): medical crew wearing PPE
Austria ÖAMTC Only ground-based transportation of confirmed cases
Italy South Tyrol
Tuscany Pegaso 1–3
Only ground-based transportation of confirmed cases
Helicopter (AW 169) medical crew wearing PPE
France Preferentially ground-based transportation of confirmed cases
Spain Preferentially ground-based transportation of confirmed cases
United
Kingdom
Preferentially ground-based transportation of confirmed cases
Poland Only ground-based transportation of confirmed cases
Hungary Only ground-based transportation of confirmed cases
Romania Only ground-based transportation of confirmed cases
Slovakia Only ground-based transportation of confirmed cases
Czech
Republic
Only ground-based transportation of confirmed cases
Norway Norwegian Air
Ambulance
Helicopter (H145 and AW 139): closed PIU (EpiShuttle®)
Royal Norwegian Air
Force
Helicopter (Sea King and Bell 412): closed PIU (EpiShuttle®)
Sweden Preferentially ground-based transportation of confirmed cases
Denmark Preferentially ground-based transportation of confirmed cases
Netherlands Helicopter (H145): medical crew wearing PPE
PIU patient isolation unit, PPE personal protective equipment
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operational backgrounds, the table is not exhaustive.
Additional patients might have been transported by add-
itional operators or in different aircraft; operational or-
ders may have been modified by the date of publication,
etc. Furthermore, not all operators provided the re-
quested information, and there are certainly additional
operators who might have transported COVID-19 pa-
tients. Nonetheless, the table provides insight into pa-
tients transported and the range of operators, as well as
into the operational infection control mechanisms in-
volved. At the moment, there is no pan-European regis-
ter for reporting numbers of transported COVID-19
patients.
For secondary missions that often last several hours, it
must be taken into account that working in full PPE
during the transport of COVID-19 patients – especially
in fixed-wing ambulances or helicopters – is very
exhausting and physically stressful for the medical team,
which may result in medical errors [3]. Furthermore,
close attention must be paid to every movement, in
order to avoid accidental disease transmission (e.g., by
touching your own face with contaminated gloves).
Therefore, for the aeromedical transport of patients with
possible or confirmed COVID-19 on secondary missions
(fixed-wing ambulances or long-lasting secondary HEMS
missions), the use of a PIU offers substantial benefits, in
spite of the higher costs and logistical requirements [5].
Closed PIUs also allow patients to be airlifted faster, as
fixed-wing ambulances or helicopters do not require
additional decontamination between transports (Fig. 2).
Another advantage of using small PIUs is the easy trans-
fer from an airplane to an ambulance or rescue helicop-
ter, or vice versa. Thus, all teams involved in
transporting these patients can be effectively protected,
and the available FFP2/3 respirators can be reserved for
use in hospitals. Both commonly used, small, closed
PIUs (EpiShuttle® and Rega PIUs) offer these advantages.
However, at present the overall number of PIUs avail-
able for Rega is actually limited because they are nor-
mally manufactured in Italy (Lombardy). With regard to
possible future epidemics or pandemics, to keep a mini-
mum number of PIUs on hand for use in the case of a
pandemic might be reasonable.
Setup and our experience with the Rega PIU
The Rega PIU (Fig. 3) comprises a flexible safety hull
stabilized by arched wires mounted on a hard floor plate.
It is maintained under negative pressure by a High Effi-
ciency Particulate Air (HEPA) filtered ventilation system
that uses aircraft power within the aircraft and battery
power when outside, while the cabin pressure is main-
tained at a standard cabin altitude of 8000 ft. During de-
velopment, it was successfully tested against infectious
agents and liquid penetration using the EN 14126 test
method and the EN ISO 17491-3 fixed-wing test, re-
spectively. Altogether, PIU barrier performance proved
equal to that provided by protective clothing. Its fixation
system allows transportation on any commonly available
patient stretcher. The PIU is designed to fit in a fixed-
wing ambulance, a medium-sized helicopter, and
ground-based ambulances (Fig. 4). Its dimensions are
200 cm*58 cm*63.5 cm. Power for the PIU ventilation is
supplied by a rechargeable battery pack (runtime of 8 h)
and a 220 V connector.
Albrecht et al. showed in 2015 [6] that a PIU undergo-
ing sudden loss of cabin pressure at a flight level of 30,
000 ft. would lose leak tightness. Consequently, the Rega
PIU features a built-in “air bag” that allows for additional
air volume expansion encountered with sudden loss of
cabin pressure [6]. Therefore, it is currently the only
available PIU that allows patient transport in pressurized
fixed-wing cabins at usual flight levels.
Plazikowski et al. compared airway management in the
Rega PIU with airway management under standard pro-
tective measures [7]. The study compared intubation of
mannequins using a standard laryngoscope, a video la-
ryngoscope, or cricothyrotomy. Overall, intubation of a
patient in the PIU was rated subjectively more difficult
compared to standard measures (Visual Analogue Scale
Fig. 2 Rega PIU HEMS: Loading or unloading of the patient in
the PIU
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76 vs. 9, p < 0.01). However, success rates in both groups
were comparable. Thus, emergency airway management
was shown to be achievable even inside the PIU.
Rega aeromedical transfer missions involving patients
with highly contagious diseases, including COVID-19,
since 2015
Fixed wing (AEMS) / Rega air ambulance jet CL605
Since 2015, Rega has successfully transferred 16 spon-
taneously breathing patients and two ventilated patient
(COVID-19) in the PIU: one patient with high-risk Ebola
virus exposure, four patients with open pulmonary tu-
berculosis, and 13 patients with confirmed COVID-19.
All transports were well tolerated, although in some
cases mild sedation was necessary.
In addition, six ventilated patients with COVID-19
were transported without the PIU. All of those patients
needed hemodynamic monitoring and two were sup-
ported with noradrenaline during the transport. Flight
duration ranged between 45 and 699 min.
Rotary wing (HEMS) / AW 109SP and/or H145
Since the beginning of the current pandemic in
Switzerland, in March 2020, eighty-three seriously ill pa-
tients (55 men, 28 women) infected with COVID-19
were transported. The majority of patients were classi-
fied as NACA 4 or 5 (NACA 4: 30 and NACA 5: 42).
Fig. 3 Two Rega PIUs in the fixed-wing ambulance
Fig. 4 Rega PIU in a ground ambulance
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Thirty-seven patients were spontaneously breathing,
forty-six were intubated and ventilated predominantly in
IPPV mode (37 IPPV, 3 CPPV, 6 PCV). Eighteen pa-
tients needed noradrenaline support for the transport.
Flight duration ranged between 5 and 59min.
Conclusion
For primary HEMS missions, SOPs for preventing the
transmission of infections during the COVID-19 or
other future pandemics need to be based on current rec-
ommendations of national medical societies/authorities,
adapted to specific circumstances of HEMS missions,
and trained in simulation. For secondary aeromedical
transport of non-intubated or intubated COVID-19 pa-
tients in fixed-wing ambulances, or for long-lasting
HEMS missions, the use of small closed PIUs may be
beneficial.
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